Approval · Notice of Compliance 21611 · 2018
BUSCOPAN: Notice of Compliance 21611
Issued December 6, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21611
- Date
- December 6, 2018
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the product labels to align with information in the pm, change the label size, change the size and placement of text on the labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BUSCOPAN | Not yet assigned | — |
Medicinal ingredients
- HYOSCINE BUTYLBROMIDE 10 MG per TAB